Background: KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration-approved injectable drug for the reduction of submental fat.
Objectives: A literature review and discussion of the treatment of submental fat.
Results: KYBELLA is a well-tolerated alternative for the treatment of submental fat.
Conclusions: KYBELLA is a safe and efficacious, first in class, injectable drug for the reduction of submental fat.